Creating tiny factories inside cells to produce cancer-fighting drugs
Pharmaceutical Nanofactories: Intracellular synthesis of bioactive drug molecules
['FUNDING_R15'] · COLORADO SCHOOL OF MINES · NIH-10439302
This study is exploring new tiny materials that can safely deliver and turn on cancer-fighting drugs right inside your cells, aiming to make treatments more effective and reduce side effects for patients like you.
Quick facts
| Phase | ['FUNDING_R15'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | COLORADO SCHOOL OF MINES (nih funded) |
| Locations | 1 site (GOLDEN, UNITED STATES) |
| Trial ID | NIH-10439302 on ClinicalTrials.gov |
What this research studies
This research focuses on developing innovative nanomaterials that can be used to deliver and activate cancer-fighting drugs directly within cells. By utilizing mesoporous silica nanoparticles, the team aims to encapsulate inactive drug molecules and catalysts that become activated in the cellular environment. This approach seeks to minimize side effects and combat drug resistance by ensuring that the drugs are only activated where they are needed. Patients may benefit from more effective treatments with fewer adverse effects.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with cancer who may benefit from advanced drug delivery systems.
Not a fit: Patients who are not diagnosed with cancer or those who do not respond to conventional therapies may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer treatments with reduced side effects and improved patient outcomes.
How similar studies have performed: Other research has shown promise in using nanotechnology for drug delivery, indicating that this approach could be a significant advancement in cancer treatment.
Where this research is happening
GOLDEN, UNITED STATES
- COLORADO SCHOOL OF MINES — GOLDEN, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: TREWYN, BRIAN — COLORADO SCHOOL OF MINES
- Study coordinator: TREWYN, BRIAN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancers, neoplasm/cancer